Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 111861663 | 11186166 | 3 | F | 2014 | 20160906 | 20150612 | 20160912 | EXP | US-JAZZ-2015-US-008404 | JAZZ | 0.00 | F | Y | 0.00000 | 20160912 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 111861663 | 11186166 | 1 | PS | XYREM | SODIUM OXYBATE | 1 | Oral | 3 G, BID | 21196 | 3 | G | ORAL SOLUTION | |||||||
| 111861663 | 11186166 | 2 | SS | XYREM | SODIUM OXYBATE | 1 | Oral | 3.5 G, BID | 21196 | 3.5 | G | ORAL SOLUTION | |||||||
| 111861663 | 11186166 | 3 | SS | XYREM | SODIUM OXYBATE | 1 | Oral | 4 G, BID | 21196 | 4 | G | ORAL SOLUTION | |||||||
| 111861663 | 11186166 | 4 | C | ABILIFY | ARIPIPRAZOLE | 1 | UNK | U | 0 | TABLET | |||||||||
| 111861663 | 11186166 | 5 | C | Vortioxetine | VORTIOXETINE | 1 | UNK | U | 0 | TABLET | |||||||||
| 111861663 | 11186166 | 6 | C | LAMICTAL | LAMOTRIGINE | 1 | UNK | U | 0 | TABLET | |||||||||
| 111861663 | 11186166 | 7 | C | SEROQUEL | QUETIAPINE FUMARATE | 1 | UNK | U | 0 | TABLET | |||||||||
| 111861663 | 11186166 | 8 | C | XANAX | ALPRAZOLAM | 1 | UNK | U | 0 | ||||||||||
| 111861663 | 11186166 | 9 | C | FLEXERIL | CYCLOBENZAPRINE HYDROCHLORIDE | 1 | UNK | U | 0 | TABLET | |||||||||
| 111861663 | 11186166 | 10 | C | MORPHINE SULFATE. | MORPHINE SULFATE | 1 | UNK | U | 0 | TABLET |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 111861663 | 11186166 | 1 | Narcolepsy |
| 111861663 | 11186166 | 4 | Product used for unknown indication |
| 111861663 | 11186166 | 5 | Product used for unknown indication |
| 111861663 | 11186166 | 6 | Product used for unknown indication |
| 111861663 | 11186166 | 7 | Product used for unknown indication |
| 111861663 | 11186166 | 8 | Product used for unknown indication |
| 111861663 | 11186166 | 9 | Product used for unknown indication |
| 111861663 | 11186166 | 10 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 111861663 | 11186166 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 111861663 | 11186166 | Anxiety | |
| 111861663 | 11186166 | Bipolar disorder | |
| 111861663 | 11186166 | Panic attack | |
| 111861663 | 11186166 | Sleep apnoea syndrome |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 111861663 | 11186166 | 1 | 201208 | 201210 | 0 | |
| 111861663 | 11186166 | 2 | 201210 | 2013 | 0 | |
| 111861663 | 11186166 | 3 | 201303 | 0 | ||
| 111861663 | 11186166 | 4 | 20150604 | 0 | ||
| 111861663 | 11186166 | 5 | 20150225 | 0 | ||
| 111861663 | 11186166 | 6 | 20120101 | 0 | ||
| 111861663 | 11186166 | 7 | 20120101 | 0 | ||
| 111861663 | 11186166 | 8 | 20110701 | 0 | ||
| 111861663 | 11186166 | 9 | 20040701 | 0 | ||
| 111861663 | 11186166 | 10 | 20030701 | 0 |